Nuvalent
NUVL
NUVL was delisted on the 14th of July, 2026.
115 hedge funds and large institutions have $2.57B invested in Nuvalent in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 56 increasing their positions, 30 reducing their positions, and 9 closing their positions.
171% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $8.28M
87% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 30
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
10% more capital invested
Capital invested by funds: $2.33B → $2.57B (+$237M)
6% more funds holding
Funds holding: 109 → 115 (+6)
0.7% more ownership
Funds ownership: 107.54% → 108.24% (+0.7%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
+$23M |
| 2 |
PA
Perceptive Advisors
New York
|
+$11.9M |
| 3 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$11.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$9.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$35M |
| 2 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$19.2M |
| 3 |
CC
Commodore Capital
New York
|
-$14.3M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.94M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.99M |
NUVL Hedge Fund Activity: Q3 2023 in Review
115 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Nuvalent (NUVL) for Q3 2023, worth a combined $2.57B — up 10% from $2.33B a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new NUVL positions and 9 closed out — a net gain of 6 holders — while 56 added to existing stakes and 30 trimmed.
The largest buyer was Paradigm Biocapital Advisors, adding an estimated $23M. The largest seller was Avoro Capital Advisors, cutting an estimated $35M.
- 115 institutional investors held Nuvalent (NUVL) as of Q3 2023, up from 109 in Q2 2023.
- Funds reported $2.57B of Nuvalent stock for Q3 2023, up 10% quarter-over-quarter.
- 15 funds opened new Nuvalent positions in Q3 2023 and 9 closed out, a net change of +6 holders.
- The largest Nuvalent buyer in Q3 2023 was Paradigm Biocapital Advisors, an estimated $23M added.
- The largest Nuvalent seller in Q3 2023 was Avoro Capital Advisors, an estimated $35M sold.
Based on aggregated 13F filings for Q3 2023.